SCHEMBL8430455

SCHEMBL8430455

C[Si](C)(C)Oc1ccc(N(CCCl)CCCl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 5/20 0.41
ERBB2 P04626 5/20 0.41
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
HIF1A Q16665 3/20 0.38
LMNA P02545 3/20 0.38
MAPT P10636 2/20 0.38
NFKB1 P19838 2/20 0.38
THPO P40225 2/20 0.38
PMP22 Q01453 2/20 0.38
GMNN O75496 1/20 0.38
CYP2D6 P10635 1/20 0.38
GABRA1 P14867 1/20 0.38
TSHR P16473 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38
SLCO1B3 Q9NPD5 1/20 0.38
CYP3A4 P08684 3/20 0.37
ALOX15 P16050 2/20 0.37
KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL659196 0.79 CA12 (0.46) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL12421704 0.73 EGFR (0.53) EGFRERBB2ALDH1A1SMN1; SMN2CYP2D6
SCHEMBL4763549 0.72 CA1 (0.39) ALDH1A1KMT2AACHETDP1MEN1
SCHEMBL10686398 0.71 EGFR (0.50) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL28878101 0.71 ALDH1A1 (0.52) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL9889321 0.71 CNR2 (0.53) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL13545738 0.70 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL14619522 0.70 EGFR (0.41) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL15097379 0.70 EGFR (0.38) EGFRERBB2ALDH1A1SMN1; SMN2HIF1A
SCHEMBL14262559 0.70 CA1 (0.34) ALDH1A1SMN1; SMN2LMNAMAPTALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6005002-A Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1999-12-21 US disclosed